Financials data is unavailable for this security.
View more
Year on year DVx Inc 's revenues fell -3.44% from 47.48bn to 45.85bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 936.19m to 172.91m, a -81.53% decrease.
| Gross margin | 10.22% |
|---|---|
| Net profit margin | 0.12% |
| Operating margin | 0.45% |
| Return on assets | 0.24% |
|---|---|
| Return on equity | 0.62% |
| Return on investment | 0.58% |
More ▼
Cash flow in JPYView more
In 2024, cash reserves at DVx Inc fell by 1.12bn. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 422.57m for operations while cash used for investing totalled 396.56m.
| Cash flow per share | 44.81 |
|---|---|
| Price/Cash flow per share | 20.40 |
| Book value per share | 842.24 |
|---|---|
| Tangible book value per share | 840.01 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.56 |
|---|---|
| Quick ratio | 1.42 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share increased 66.67% while earnings per share excluding extraordinary items fell by -81.59%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is below the industry average.
| Div yield(5 year avg) | 3.04% |
|---|---|
| Div growth rate (5 year) | 15.81% |
| Payout ratio (TTM) | 937.54% |
| EPS growth(5 years) | -28.46 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -92.63 |
More ▼
